Online inquiry

IVTScrip™ mRNA-Human ANKRD28, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK18514MR)

This product GTTS-WK18514MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ANKRD28 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001195098.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23243
UniProt ID O15084
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD28, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK18514MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK11659MR IVTScrip™ mRNA-Human ADORA2A, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADORA2A
GTTS-WK9870MR IVTScrip™ mRNA-Human ADRBK2, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADRBK2
GTTS-WK24994MR IVTScrip™ mRNA-Human ARHGAP3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP3
GTTS-WK12580MR IVTScrip™ mRNA-Human AFAP1L2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AFAP1L2
GTTS-WK9835MR IVTScrip™ mRNA-Human ADGRD2, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADGRD2
GTTS-WK20319MR IVTScrip™ mRNA-Human ANKRD36, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKRD36
GTTS-WK28603MR IVTScrip™ mRNA-Human ARHGAP9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP9
GTTS-WK22209MR IVTScrip™ mRNA-Human API5, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA API5
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW